Biomarker Discovery Outsourcing Services Market, By Type (Safety Biomarkers, Predictive Biomarkers, Surrogate Endpoints, Prognostic Biomarkers and Others), By Service, By Therapeutic Area, By End Use, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
ANV6330
|
Published Date
November 2026
|
Pages
280
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Biomarker Discovery Outsourcing Services market size was valued at US$ 5,190.5 Million in 2025, expanding at a CAGR of 20.8% from 2026 to 2033.
Biomarker discovery outsourcing services are a specific type of research which drug developers and diagnostics companies outsource to third parties such as contract research organisations. A biomarker is a measurable sign in the body, such as changes in genes, proteins or metabolites, that can be measured to determine if a patient has a disease, the progression of that disease, and whether the patient will respond to treatment. The outsourced work typically covers include analysing samples, identifying, validating and interpreting data using advanced technology such as genomic sequencing, proteomics and bioinformatics. This allows pharmaceutical and biotech companies to speed up their processes, reduce costs and focus on developing their drugs, as they are outsourcing to experts who have the high-cost equipment and knowledge. These services support faster drug development, improve research accuracy, and help companies identify reliable biomarkers for better treatment outcomes.
Biomarker Discovery Outsourcing Services Market- Market Dynamics
Rising Focus On Personalized Medicine To Drive Market Demand
The primary driver of the Biomarker Discovery Outsourcing Services market includes increasing emphasis on personalised medicine. Biomarkers help to recognise unique characteristics of diseases, and hence targeted therapies can be developed, resulting in better patient care. In March 2026, according to a Press Information Bureau (PIB) press release, India has been making strides towards personalised and precise medicine due to the high genetic diversity in India, which consists of more than 4,000 – 5,000 different communities. The Genome India project has already sequenced 10,000 genomes from Indians with the goal of reaching one million genome sequences in the future. These increasing genomics assets will help in predictive healthcare, diagnostics and customised treatment, leading to increased emphasis on personalised medicine.
Biomarker Discovery Outsourcing Services Market- Segmentation Analysis:
The Global Biomarker Discovery Outsourcing Services market is segmented on the basis of Type, Service, Therapeutic Area, End Use, and Region.
Under service, genomics biomarker services hold a prominent position in the market. Genomic profiling helps researchers to identify genetic alterations responsible for the disease from one single sample. This is particularly important in terms of precision medicine, patient selection, and companion diagnostics development. As modern drug programmes usually start with identifying genetic information, the sponsors of the programme tend to outsource the procedure. In August 2026, McKesson announced its plan to acquire Precision Medicine Group for US$2.25 billion. This case demonstrates the increasing relevance of genomics and biomarkers within the precision medicine and drug development industry. The increasing dependence on genomics is generating the demand for biomarker services within the precision.
Biomarker Discovery Outsourcing Services Market- Geographical Insights
North America holds a key Biomarker Discovery Outsourcing Services market because of the personalised big pharmaceutical and bioregionalism, large R&D investment, developed structure of contract research, and developed healthcare and regulations. In September 2026, according to the India Research America Org report, the growing rate of investments in the area of medical and health research and development contributes to the innovation in such areas as the biomarker research field. The total US investment in medical and health research and development reached diagnostics-ill customised. The industry investments were equal to $196, personalizing and taking up 66.1% of the total investments made. The academic and research institutions\' investment was estimated at $29.9 billion. In 2025, the academic and research institutions\' investment increased by 31.4%. These strong research investments and established industry capabilities continue to support North America\'s growth in biomarker discovery outsourcing services.
Biomarker Discovery Outsourcing Services Market- Competitive Landscape:
The market can be considered somewhat fragmented, with big full-service research organisations and specialised biomarker and discovery providers vying for market share. Among those that occupy leading positions within the market, it is possible to mention Thermo Fisher Scientific (PPD), IQVIA, Charles River Laboratories, Bio-Rad Laboratories and ICON plc. These companies have different advantages such as lab scale, science knowledge, data and established relationships. In July 2025, Bio-Rad Laboratories, Inc., introduced four ddPCR platforms, namely the QX Continuum system and the QX700 series, obtained from Stilla Technologies. These platforms ensure advanced multiplexing and high-precision quantification of nucleic acids for research in life sciences, molecular diagnostics and biomarkers studies. These devices allow enhancing the efficiency of packaging operations through increased production rates, ensured product quality and reduced expenses.
Recent Developments:
- In May 2026, Sino Biological Inc. launched their XPressMAX™ Cell-Free Protein Synthesis Kit to help with AI-driven high-throughput antibody discovery. This technology allows for fast production in vitro of proteins and antibodies in around 3 hours, helping researchers accelerate antibody screening, protein engineering, and drug discovery activities.
- In June 2025, RayBiotech Life, Inc., entered into a strategic partnership with Venebio Group via a master services agreement. This will allow drug and diagnostic developers to utilise RayBiotech’s proteomics platforms and biomarker discovery services alongside Venebio’s expertise in regulatory strategy, clinical trial design and drug safety analytics. This will help improve biomarker research, clinical assay development and diagnostic development services.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Almac Group Limited
- Crown Bioscience
- Evotec SE
- Frontage Laboratories, Inc.
- Excelra
- Parexel International Corporation
- Bio-Rad Laboratories, Inc.
- Sino Biological Inc.
- Emery Pharma
- RayBiotech, Inc.
- REPROCELL Inc.
- Selvita S.A.
- Svar Life Science AB
- Sapient Bioanalytics
- Precision for Medicine, Inc.
- Charles River Laboratories International, Inc.
- Others
GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033
- Safety Biomarkers
- Predictive Biomarkers
- Surrogate Endpoints
- Prognostic Biomarkers
- Others
GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET, BY SERVICE- MARKET ANALYSIS, 2020 - 2033
- Bioinformatics Biomarker Services
- Genomics Biomarker Services
- Proteomics Biomarker Services
- Others
GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2020 - 2033
- Autoimmune Diseases
- Neurology
- Oncology
- Cardiology
- Others
GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET, BY END USE- MARKET ANALYSIS, 2020 - 2033
- Biotechnology Companies
- Pharmaceutical Companies
- Others
GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
TABLE OF CONTENT
1. Biomarker Discovery Outsourcing Services Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.2. Competitive Insights
3. Biomarker Discovery Outsourcing Services Key Market Trends
3.1. Biomarker Discovery Outsourcing Services Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Biomarker Discovery Outsourcing Services Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Biomarker Discovery Outsourcing Services Market Opportunities
3.4. Biomarker Discovery Outsourcing Services Market Future Trends
4. Biomarker Discovery Outsourcing Services Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Biomarker Discovery Outsourcing Services Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Biomarker Discovery Outsourcing Services Market Landscape
6.1. Biomarker Discovery Outsourcing Services Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Biomarker Discovery Outsourcing Services Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2025 & 2033 (%)
7.1.2. Safety Biomarkers
7.1.3. Predictive Biomarkers
7.1.4. Surrogate Endpoints
7.1.5. Prognostic Biomarkers
7.1.6. Others
8. Biomarker Discovery Outsourcing Services Market – By Service
8.1. Overview
8.1.1. Segment Share Analysis, By Service, 2025 & 2033 (%)
8.1.2. Bioinformatics Biomarker Services
8.1.3. Genomics Biomarker Services
8.1.4. Proteomics Biomarker Services
8.1.5. Others
9. Biomarker Discovery Outsourcing Services Market – By Therapeutic Area
9.1. Overview
9.1.1. Segment Share Analysis, By Therapeutic Area, 2025 & 2033 (%)
9.1.2. Autoimmune Diseases
9.1.3. Neurology
9.1.4. Oncology
9.1.5. Cardiology
9.1.6. Others
10. Biomarker Discovery Outsourcing Services Market – By End Use
10.1. Overview
10.1.1. Segment Share Analysis, By End Use, 2025 & 2033 (%)
10.1.2. Biotechnology Companies
10.1.3. Pharmaceutical Companies
10.1.4. Others
11. Biomarker Discovery Outsourcing Services Market – By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
11.2. North America
11.2.1. Overview
11.2.2. Biomarker Discovery Outsourcing Services Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.2.4. North America Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.2.5. North America Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.2.6. North America Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.2.7. North America Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Biomarker Discovery Outsourcing Services Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.17. Denmark
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.17.3. Denmark Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.17.4. Denmark Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.3.17.5. Denmark Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.3.17.6. Denmark Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.18. Rest of Europe
11.3.18.1. Overview
11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.18.3. Rest of the Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.18.4. Rest of the Europe Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.3.18.5. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.3.18.6. Rest of the Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Biomarker Discovery Outsourcing Services Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.16. Taiwan
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.16.3. Taiwan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.16.4. Taiwan Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.4.16.5. Taiwan Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.4.16.6. Taiwan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.17. Vietnam
11.4.17.1. Overview
11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.17.3. Vietnam Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.17.4. Vietnam Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.4.17.5. Vietnam Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.4.17.6. Vietnam Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.18. Rest of APAC
11.4.18.1. Overview
11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.18.3. Rest of APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.18.4. Rest of APAC Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.4.18.5. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.4.18.6. Rest of APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Biomarker Discovery Outsourcing Services Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Biomarker Discovery Outsourcing Services Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.14. Iran
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.14.3. Iran Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.14.4. Iran Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.6.14.5. Iran Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.6.14.6. Iran Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.15. Qatar
11.6.15.1. Overview
11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.15.3. Qatar Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.15.4. Qatar Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.6.15.5. Qatar Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.6.15.6. Qatar Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.16. Rest of MEA
11.6.16.1. Overview
11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.16.3. Rest of MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.16.4. Rest of MEA Market Size and Forecast, By Service, 2020 - 2033 (US$ Million)
11.6.16.5. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
11.6.16.6. Rest of MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
12. Key Vendor Analysis- Biomarker Discovery Outsourcing Services Industry
12.1. Competitive Benchmarking
12.1.1. Competitive Dashboard
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Almac Group Limited
12.2.2. Crown Bioscience
12.2.3. Evotec SE
12.2.4. Frontage Laboratories, Inc.
12.2.5. Excelra
12.2.6. Parexel International Corporation
12.2.7. Bio-Rad Laboratories, Inc.
12.2.8. Sino Biological Inc.
12.2.9. Emery Pharma
12.2.10. RayBiotech, Inc.
12.2.11. REPROCELL Inc.
12.2.12. Selvita S.A.
12.2.13. Svar Life Science AB
12.2.14. Sapient Bioanalytics
12.2.15. Precision for Medicine, Inc.
12.2.16. Charles River Laboratories International, Inc.
12.2.17. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Almac Group Limited
- Crown Bioscience
- Evotec SE
- Frontage Laboratories, Inc.
- Excelra
- Parexel International Corporation
- Bio-Rad Laboratories, Inc.
- Sino Biological Inc.
- Emery Pharma
- RayBiotech, Inc.
- REPROCELL Inc.
- Selvita S.A.
- Svar Life Science AB
- Sapient Bioanalytics
- Precision for Medicine, Inc.
- Charles River Laboratories International, Inc.
- Others
GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033
- Safety Biomarkers
- Predictive Biomarkers
- Surrogate Endpoints
- Prognostic Biomarkers
- Others
GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET, BY SERVICE- MARKET ANALYSIS, 2020 - 2033
- Bioinformatics Biomarker Services
- Genomics Biomarker Services
- Proteomics Biomarker Services
- Others
GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2020 - 2033
- Autoimmune Diseases
- Neurology
- Oncology
- Cardiology
- Others
GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET, BY END USE- MARKET ANALYSIS, 2020 - 2033
- Biotechnology Companies
- Pharmaceutical Companies
- Others
GLOBAL BIOMARKER DISCOVERY OUTSOURCING SERVICES MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Analystview Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
